216 related articles for article (PubMed ID: 9151877)
21. Characterization of the R572T point mutant of a putative cleavage site in human foamy virus Env.
Bansal A; Shaw KL; Edwards BH; Goepfert PA; Mulligan MJ
J Virol; 2000 Mar; 74(6):2949-54. PubMed ID: 10684317
[TBL] [Abstract][Full Text] [Related]
22. Replacement of the murine leukemia virus (MLV) envelope gene with a truncated HIV envelope gene in MLV generates a virus with impaired replication capacity.
Nack U; Schnierle BS
Virology; 2003 Oct; 315(1):209-16. PubMed ID: 14592772
[TBL] [Abstract][Full Text] [Related]
23. Receptor-specific targeting mediated by the coexpression of a targeted murine leukemia virus envelope protein and a binding-defective influenza hemagglutinin protein.
Lin AH; Kasahara N; Wu W; Stripecke R; Empig CL; Anderson WF; Cannon PM
Hum Gene Ther; 2001 Mar; 12(4):323-32. PubMed ID: 11242525
[TBL] [Abstract][Full Text] [Related]
24. Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein increases env incorporation into particles and fusogenicity and infectivity.
Zingler K; Littman DR
J Virol; 1993 May; 67(5):2824-31. PubMed ID: 8474176
[TBL] [Abstract][Full Text] [Related]
25. Envelope proteins of spleen necrosis virus form infectious human immunodeficiency virus type 1 pseudotype vector particles, but fail to incorporate upon substitution of the cytoplasmic domain with that of Gibbon ape leukemia virus.
Stitz J; Wolfrum N; Buchholz CJ; Cichutek K
J Gen Virol; 2006 Jun; 87(Pt 6):1577-1581. PubMed ID: 16690921
[TBL] [Abstract][Full Text] [Related]
26. Cells expressing the human foamy virus (HFV) accessory Bet protein are resistant to productive HFV superinfection.
Bock M; Heinkelein M; Lindemann D; Rethwilm A
Virology; 1998 Oct; 250(1):194-204. PubMed ID: 9770433
[TBL] [Abstract][Full Text] [Related]
27. Molecular and phylogenetic analyses of a new amphotropic murine leukemia virus (MuLV-1313).
Howard TM; Sheng Z; Wang M; Wu Y; Rasheed S
Virol J; 2006 Dec; 3():101. PubMed ID: 17147829
[TBL] [Abstract][Full Text] [Related]
28. Analysis of HIV-1 envelope mutants and pseudotyping of replication-defective HIV-1 vectors by genetic complementation.
Delwart EL; Buchschacher GL; Freed EO; Panganiban AT
AIDS Res Hum Retroviruses; 1992 Sep; 8(9):1669-77. PubMed ID: 1457211
[TBL] [Abstract][Full Text] [Related]
29. The human foamy virus pol gene is expressed as a Pro-Pol polyprotein and not as a Gag-Pol fusion protein.
Löchelt M; Flügel RM
J Virol; 1996 Feb; 70(2):1033-40. PubMed ID: 8551561
[TBL] [Abstract][Full Text] [Related]
30. Targeting retroviral vectors to CD34-expressing cells: binding to CD34 does not catalyze virus-cell fusion.
Benedict CA; Tun RY; Rubinstein DB; Guillaume T; Cannon PM; Anderson WF
Hum Gene Ther; 1999 Mar; 10(4):545-57. PubMed ID: 10094198
[TBL] [Abstract][Full Text] [Related]
31. Antibody-mediated targeting of replication-competent retroviral vectors.
Tai CK; Logg CR; Park JM; Anderson WF; Press MF; Kasahara N
Hum Gene Ther; 2003 May; 14(8):789-802. PubMed ID: 12804141
[TBL] [Abstract][Full Text] [Related]
32. A potential live vector, foamy virus, directed intra-cellular expression of ovine interferon-tau exhibited the resistance to HIV infection.
Fujii Y; Murase Y; Otake K; Yokota Y; Omoto S; Hayashi H; Okada H; Okada N; Kawai M; Okuyama H; Imakawa K
J Vet Med Sci; 2004 Feb; 66(2):115-21. PubMed ID: 15031537
[TBL] [Abstract][Full Text] [Related]
33. The human foamy virus internal promoter is required for efficient gene expression and infectivity.
Löchelt M; Yu SF; Linial ML; Flügel RM
Virology; 1995 Jan; 206(1):601-10. PubMed ID: 7831816
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the functional and host range-determining regions of the murine ectropic and amphotropic retrovirus envelope proteins.
Morgan RA; Nussbaum O; Muenchau DD; Shu L; Couture L; Anderson WF
J Virol; 1993 Aug; 67(8):4712-21. PubMed ID: 8331726
[TBL] [Abstract][Full Text] [Related]
35. Helper-free foamy virus vectors.
Trobridge GD; Russell DW
Hum Gene Ther; 1998 Nov; 9(17):2517-25. PubMed ID: 9853518
[TBL] [Abstract][Full Text] [Related]
36. Isolation and sequencing of infectious clones of feline foamy virus and a human/feline foamy virus Env chimera.
Hatama S; Otake K; Omoto S; Murase Y; Ikemoto A; Mochizuki M; Takahashi E; Okuyama H; Fujii Y
J Gen Virol; 2001 Dec; 82(Pt 12):2999-3004. PubMed ID: 11714976
[TBL] [Abstract][Full Text] [Related]
37. Membrane-proximal cytoplasmic domain of Moloney murine leukemia virus envelope tail facilitates fusion.
Rozenberg-Adler Y; Conner J; Aguilar-Carreno H; Chakraborti S; Dimitrov DS; Anderson WF
Exp Mol Pathol; 2008 Feb; 84(1):18-30. PubMed ID: 18222422
[TBL] [Abstract][Full Text] [Related]
38. Cell targeting with retroviral vector particles containing antibody-envelope fusion proteins.
Chu TH; Martinez I; Sheay WC; Dornburg R
Gene Ther; 1994 Sep; 1(5):292-9. PubMed ID: 7584094
[TBL] [Abstract][Full Text] [Related]
39. Viral determinants that control the neuropathogenicity of PVC-211 murine leukemia virus in vivo determine brain capillary endothelial cell tropism of the virus in vitro.
Masuda M; Hoffman PM; Ruscetti SK
J Virol; 1993 Aug; 67(8):4580-7. PubMed ID: 8392599
[TBL] [Abstract][Full Text] [Related]
40. The gene expression of human foamy virus does not require a post-transcriptional transactivator.
Lee AH; Lee HY; Sung YC
Virology; 1994 Oct; 204(1):409-13. PubMed ID: 7522374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
